# RpoS impacts global gene expression and carbon source utilization in Escherichia coli O104:H4

**Authors:** Petya Berger, Karla Bosse-Plois, Wolfgang Pölking, David Loewe, Ian U. Kouzel, Michael Berger, Ulrich Dobrindt, Alexander Mellmann

PMC · DOI: 10.3389/fmicb.2025.1758449 · Frontiers in Microbiology · 2026-01-20

## TL;DR

A mutation in the RpoS gene affects how E. coli O104:H4 uses carbon sources and increases its virulence.

## Contribution

The study reveals how a specific RpoS mutation alters gene expression and carbon utilization in a pathogenic E. coli strain.

## Key findings

- The rpoS ATG > ATA mutation activates metabolic pathways and represses carbon source utilization genes.
- The ΔrpoS strain assimilates amino acids more efficiently and shows a competitive advantage in amino acid-rich environments.
- RpoS is identified as a central regulator of gene expression and carbon source utilization in pathogenic E. coli.

## Abstract

Escherichia coli (E. coli) O104:H4 caused the 2011 enterohemorrhagic E. coli (EHEC) outbreak in Germany, which remains the outbreak with the highest incidence of hemolytic uremic syndrome worldwide. We recently identified an E. coli O104:H4 isolate carrying a single nucleotide polymorphism in the start codon (ATG > ATA) of rpoS, which encodes the alternative sigma factor RpoS, resulting in reduced RpoS levels and enhanced virulence gene expression.

Gene set enrichment analysis further revealed that the rpoS ATG > ATA mutation was primarily associated with activation of numerous metabolic pathways and repression of carbon source utilization-related transporter and transcription factor genes. Consistently, BIOLOG phenotype microarrays showed that E. coli O104:H4 rpoS ATG > ATA assimilated amino acids and organic acids (TCA cycle substrates) more efficiently, whereas the wild type strain displayed stronger metabolic respiration with sugars and sugar derivatives, including constituents of the mucus. Deletion of rpoS (ΔrpoS) in E. coli O104:H4 Δstx2 resulted in a carbon source utilization profile similar to the one of rpoS ATG > ATA, as well as in enhanced growth in minimal medium supplemented with amino acids and reduced one with sugars. Moreover, co-culture experiments with E. coli O104:H4 Δstx2 and E. coli O104:H4 Δstx2 ΔrpoS revealed a strong competitive advantage of the ΔrpoS strain with the tested amino acids; however, no advantage of the rpoS-intact strain was observed with sugars.

Our findings elucidate the impact of RpoS on global gene expression and carbon source utilization in E. coli O104:H4, further underscoring its role as a central regulator in pathogenic bacteria.

## Linked entities

- **Genes:** rpoS (RNA polymerase sigma factor RpoS) [NCBI Gene 880421], STX2 (syntaxin 2) [NCBI Gene 2054]
- **Proteins:** rpoS (RNA polymerase sigma factor RpoS)
- **Diseases:** hemolytic uremic syndrome (MONDO:0001549)
- **Species:** Escherichia coli (taxon 562), Escherichia coli O104:H4 (taxon 1038927)

## Full-text entities

- **Diseases:** EHEC (MESH:D004927), hemolytic uremic syndrome (MESH:D006463)
- **Chemicals:** carbon (MESH:D002244), TCA (MESH:D014238), amino acids (MESH:D000596), sugar (MESH:D000073893), organic acids (-)
- **Species:** Escherichia coli O104:H4 (no rank) [taxon 1038927]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12864459/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12864459/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC12864459/full.md

---
Source: https://tomesphere.com/paper/PMC12864459